8.63
-0.35
(-3.90%)
At close: April 10 at 4:00:00 PM EDT
8.63
0.00
(0.00%)
After hours: April 10 at 4:20:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
Operating Expense
83,055
83,055
36,179
Operating Income
-83,055
-83,055
-36,179
Net Non Operating Interest Income Expense
12,138
12,138
2,527
Other Income Expense
-7,390
-7,390
-1,124
Pretax Income
-78,307
-78,307
-34,776
Tax Provision
--
--
10
Net Income Common Stockholders
-78,307
-78,307
-34,786
Diluted NI Available to Com Stockholders
-78,307
-78,307
-34,786
Basic EPS
-3.78
--
-23.10
Diluted EPS
-3.78
--
-23.10
Basic Average Shares
20,738.34
--
1,505.77
Diluted Average Shares
20,738.34
--
1,505.77
Total Operating Income as Reported
-83,055
-83,055
-36,179
Total Expenses
83,055
83,055
36,179
Net Income from Continuing & Discontinued Operation
-78,307
-78,307
-34,786
Normalized Income
-78,307
-78,307
-34,786
Interest Income
12,138
12,138
2,527
Net Interest Income
12,138
12,138
2,527
EBIT
-83,055
-83,055
-36,179
EBITDA
-82,216
-82,216
-36,067
Reconciled Depreciation
839
839
112
Net Income from Continuing Operation Net Minority Interest
-78,307
-78,307
-34,786
Total Unusual Items Excluding Goodwill
--
--
-1,124
Total Unusual Items
--
--
-1,124
Normalized EBITDA
-82,216
-82,216
-36,067
Tax Rate for Calcs
--
--
0
12/31/2023 - 6/7/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MAZE Maze Therapeutics, Inc.
7.60
-4.64%
ABVX ABIVAX Société Anonyme
5.59
-4.61%
AVBP ArriVent BioPharma, Inc.
16.86
-3.99%
CNTA Centessa Pharmaceuticals plc
11.27
-4.17%
KRRO Korro Bio, Inc.
12.97
-4.35%
MLYS Mineralys Therapeutics, Inc.
12.19
-4.99%
XENE Xenon Pharmaceuticals Inc.
30.73
-2.72%
APGE Apogee Therapeutics, Inc.
29.94
-5.85%
ALMS Alumis Inc.
6.83
-15.05%
TRVI Trevi Therapeutics, Inc.
5.28
-2.22%